✦ LIBER ✦

On the relationship between nausea and vomiting in patients undergoing chemotherapy

✍ Scribed by Italian Group for Antiemetic Research

Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 575 KB
Volume: 2
Category: Article
ISSN: 0941-4355
DOI: 10.1007/bf00417476

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ondansetron versus granisetron in the pr

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting

✍ Paola Fedele; Michele Spina; Mariagrazia Valentini; Doriana Collini; Cadorin Luc 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Metoclopramide in the reduction of nause

Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy

✍ Robert Cox; Christopher E. Newman; Michael J. Leyland 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 276 KB

Tropisetron in the prevention of nausea

Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy

✍ Benoit, Yves ;Hulstaert, Frank ;Vermylen, Christiane ;Sariban, Eric ;Hoyoux, Cla 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

## Abstract Tropisetron (Navoban®, Sandoz Pharma Ltd., Basel, Switzerland), a selective antagonist of the serotonin receptor (5‐HT3) dosed once‐daily at 0.2 mg/kg (with a maximum of 5 mg daily), was evaluated in the prevention of chemotherapy‐induced nausea and vomiting in 131 children with a media

Tropisetron (Navoban) in the prevention

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting — the Nordic experience

✍ Bengt Sorbe; Håkan Andersson; Margareta Schmidt; Martin Söderberg; Thomas Högber 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 911 KB

Continuous infusion of high-dose metoclo

Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ R. A. Joss; R. L. Galeazzi; K. W. Brunner 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 580 KB

Daily palonosetron is superior to ondans

Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia

✍ Gloria N. Mattiuzzi; Jorge E. Cortes; Deborah A. Blamble; B. Nebiyou Bekele; Lia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views